- Products
- Reproduction
- Molecular diagnostics
- Careers
- About us
- Contacts
EMBRACE (Embryo Analysis of Culture Environment) is a non-invasive method of genetic testing of embryos (niPGT-A) that analyzes DNA released into the embryo’s culture medium – without the need for a biopsy.
Why choose EMBRACE?
Developed with both patient comfort and result quality in mind, EMBRACE offers an alternative to conventional PGT-A. It uses DNA sequencing obtained directly from the environment in which the embryo is cultured, enabling the selection of embryos that are most likely to have the correct number of chromosomes.
Advantages of the EMBRACE test:
Non-invasive – no disturbance to the embryo
Safe – no need for an invasive biopsy
Accurate – helps identify embryos with a high probability of euploidy (normal chromosome number)
Supports embryo selection – increases the chances of a successful pregnancy
Compatible with IVF laboratories – easy integration without special modifications to workflows
Who is EMBRACE suitable for?
For couples undergoing IVF treatment who wish to support the selection of a suitable embryo without a genetic biopsy – especially in cases where invasive PGT-A is unsuitable or undesirable.
How does the test work?
The embryo is cultured to the blastocyst stage (day 6).
The culture medium in which the embryo developed is sent to the laboratory.
DNA is extracted from the medium and analyzed using NGS (next-generation sequencing).
The result helps determine the probability that the embryo is euploid.
A reliable tool for non-invasive decision support
The EMBRACE test offers a new perspective on embryo assessment – by combining advanced technology with a gentle approach to embryos, it increases the success rates of assisted reproduction.
For more information, please contact us by e-mail: reprodukce@pentagen.cz